Published in Hepatitis Weekly, April 15th, 2002
Under the terms of this agreement, Gradipore will provide a customized Gradiflow platform for transfer to Biomira.
The agreement provides for the payment of certain performance-based fees to Gradipore. Further financial details and terms were not disclosed.
Gradipore's core separations technology platform, Gradiflow, is a membrane-based process for large-scale biological separations and has applications in research, scientific, and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly